Provided by Tiger Trade Technology Pte. Ltd.

ANI Pharmaceuticals

70.19
-1.2700-1.78%
Post-market: 70.190.00000.00%16:10 EDT
Volume:329.19K
Turnover:23.20M
Market Cap:1.61B
PE:15.46
High:71.92
Open:71.53
Low:69.58
Close:71.46
52wk High:99.39
52wk Low:69.58
Shares:22.97M
Float Shares:20.28M
Volume Ratio:1.23
T/O Rate:1.62%
Dividend:- -
Dividend Rate:- -
EPS(TTM):4.54
EPS(LYR):3.32
ROE:20.46%
ROA:5.45%
PB:2.70
PE(LYR):21.14

Loading ...

U.S. Research Roundup-Compass Minerals, Duke Energy, Tesla

Reuters
·
Aug 10

ANI Pharmaceuticals Inc : Canaccord Genuity Cuts Target Price to $90 from $91

THOMSON REUTERS
·
Aug 10

ANI Pharmaceuticals (ANIP) Stock Slides As Cortrophin Concentration Clouds Profit Quality

Simply Wall St.
·
Aug 09

Sector Update: Healthcare Stocks Rise Late Afternoon

MT Newswires Live
·
Aug 08

ANI Pharmaceuticals Slides After Lowering FY26 Guidance for Cortrophin Gel Revenue

Dow Jones
·
Aug 07

ANI Pharmaceuticals, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 07

ANI Pharma Cuts Full-Year Revenue Forecast for Key Drug; Shares Fall

Reuters
·
Aug 07

ANI Pharma Investor Presentation Spotlights Rare Disease Shift, Targets 2026 Net Revenue of $1.1 Billion

Reuters
·
Aug 07

ANI Pharmaceuticals Shares Down 8.1% Premarket After Co Forecasts 2026 Revenue Below Estimates

THOMSON REUTERS
·
Aug 07

GUIDANCE: (ANIP) ANI Pharmaceuticals Expects 2026 Adjusted EPS Range $9.19 - $9.69, vs. FactSet Est of $9.45

MT Newswires Live
·
Aug 07

ANI Pharma Q2 FY26 GAAP Net Income Climbs 203.5% to $24.7 Million; Net Revenues Rise 25.9% to $266 Million

Reuters
·
Aug 07

ANI Pharmaceuticals Q2 Adjusted EPS USD 2.21 Vs. IBES Estimate USD 2.05

Reuters
·
Aug 07

ANI Pharmaceuticals Q2 Adjusted Ebitda USD 71.6 Million

THOMSON REUTERS
·
Aug 07

ANI Pharmaceuticals Q2 Net Income USD 24.7 Million

THOMSON REUTERS
·
Aug 07

ANI Pharmaceuticals Reports Record Second Quarter 2026 Financial Results

THOMSON REUTERS
·
Aug 07

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Aug 07

Barclays Sticks to Their Buy Rating for ANI Pharmaceuticals (ANIP)

TIPRANKS
·
Aug 05

Earning Preview: ANI Pharmaceuticals this quarter’s revenue is expected to increase by 36.70%, and institutional views are bullish

Earnings Agent
·
Jul 31

ANI Pharmaceuticals to Discuss Second Quarter 2026 Financial Results on August 7, 2026 at 8:00 a.m. ET

GlobeNewswire
·
Jul 24

ANI Pharmaceuticals (ANIP) Stock Looks Fairly Valued With Strong Returns But Mixed Earnings

Simply Wall St.
·
Jul 18